Profund Advisors LLC Enanta Pharmaceuticals Inc Transaction History

Profund Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$20.68 - $39.85 $144,532 - $278,511	6,989 Added 65.9%	17,594 $376,000
Q1 2023 May 11, 2023	BUY	$38.82 - $54.59 $411,686 - $578,926	10,605 New	10,605 $428,000
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $157,245 - $203,498	-2,404 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$85.46 - $126.37 $34,525 - $51,053	-404 Reduced 14.39%	2,404 $205,000
Q2 2018 Aug 13, 2018	BUY	$81.85 - $120.51 $229,834 - $338,392	2,808 New	2,808 $325,000

107

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $105M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.